Heather Hogan - Hemostasis Today | Hemostasis News, Insights, Stories

Voices Science Insight Innovation

Headlines Hematology Health Medicine VTE ASH Plasma Donation

June, 2026

Heather Hogan

Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26

Apr 1, 2026, 15:18 | Science

Gregory Piazza: Proud Moment for Thrombosis Research Group at ACC.26

Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…

Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm

Nov 26, 2025, 04:51 | Science

Apixaban for Extended Treatment of Provoked VTE: New NEJM Study Challenges Treatment Paradigm

Emma P. with Clinical Research Professionals shared a post on LinkedIn: "Apixaban for Extended Treatment…

Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines

Oct 12, 2025, 10:14 | Science

Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines

Hatim Lokhandwala, Clinical Research Coordinator, Hope & Healing Cancer Services LLC, shared a post on LinkedIn:…

Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress

Sep 16, 2025, 11:25 | Science

Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress

Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on…

Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results

Aug 31, 2025, 07:23 | Science

Extended Low-Dose Apixaban After Provoked VTE: Marc Carrier Spotlights Major NEJM Results

Marc Carrier, Professor at Ottawa Hospital Research Institute, has posted on X: ''New in…

Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results

Aug 30, 2025, 14:43 | Science

Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results

Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, shared a…

All: 6 Posts: 1 - 100

'

Wolfgang Miesbach: CMA CAR-T Induces Immune Reset and Durable Remission in Refractory ITP - EHA 2026 Late-Breaking Update

'

Thrombosis in Cancer Patients: Why It Happens and How We Treat It Today

'

Turning Antithrombotic Stewardship into Practice - Anticoagulation Forum

'

Ney Carter Borges: Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease - Lessons From the TRACK Trial

'

What Would You Like to Know About Hemophilia Gene Therapy? - ISTH

Jun 8, 2026, 12:21
William Aird: Developing Patient-Facing Educational Material for The Blood Project
Jun 8, 2026, 12:02
Glanzmann Thrombasthenia – A Rare but Important Platelet Disorder – Iranian Comprehensive Hemophilia Care Center
Jun 8, 2026, 06:30
Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
Jun 8, 2026, 06:25
Cécile Jefford: The NEHA Community and the Power of Human Connection
Jun 8, 2026, 06:02
Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
Jun 8, 2026, 03:05
Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
Jun 8, 2026, 03:03
Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
Jun 8, 2026, 02:59
Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
Jun 7, 2026, 22:11
Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity